Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Pfizer's stock price increase by 10% or more by Nov 30, 2024 following TALAPRO-2 results?  | Binary | 3 | 2 months ago | ||
Will the FDA approve the Talzenna-Xtandi combo for mCRPC by end of 2024? | Binary | 2 | 2 months ago | ||
Will Talzenna-Xtandi combo become the standard treatment for mCRPC by end of 2025? | Binary | 2 | 2 months ago | ||
What will be the market share of Talzenna-Xtandi combo in mCRPC treatments by end of 2025? | Categorical | 2 | 2 months ago | ||
How many new mCRPC treatment combinations will FDA approve by end of 2025? | Categorical | 2 | 2 months ago | ||
What will be the Talzenna-Xtandi combo's ranking in global oncology drug sales by end of 2025? | Categorical | 2 | 2 months ago |